NDC 80425-0594-01 - Lidocaine
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 80425-0594
- Requested NDC
- 80425-0594-01
- Package NDCs from labels
- 80425-0594-1, 80425-0594-01
- Manufacturer
- Advanced Rx of Tennessee, LLC
- Effective date
- 2026-09-10
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Lidocaine - Advanced Rx of Tennessee, LLC | Advanced Rx of Tennessee, LLC | 2026-09-10 | HUMAN PRESCRIPTION DRUG LABEL |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Good Neighbor Pharmacy ClearLax | POLYETHYLENE GLYCOL 3350 | Amerisource Bergen | 4f2d3ef2-5097-4653-8dab-de5ba1fb9c41 | 2026-09-28 | Warnings | G2M7P15E5P |
| Lidocaine | LIDOCAINE | Direct_Rx | 5c8f1543-ef1f-b632-e063-6394a90ace6a | 2026-09-28 | Warnings, Adverse reactions | 1543069 98PI200987 |
| berkley and jensen clearlax | POLYETHYLENE GLYCOL 3350 | BJWC | f9eb9023-c83b-49b4-af82-d8344ffa46c3 | 2026-09-28 | Warnings | G2M7P15E5P |
| clear lax | POLYETHYLENE GLYCOL 3350 | H E B | bd16827b-5e6a-4fa7-bc2e-c9a05e1e2dab | 2026-09-28 | Warnings | G2M7P15E5P |
| equaline clearlax | POLYETHYLENE GLYCOL 3350 | United Natural Foods, Inc. dba UNFI | e0871542-9136-4cf8-a4b7-6c2b6edcbe0e | 2026-09-28 | Warnings | G2M7P15E5P |
| Frnxuc Lidocaine patches | LIDOCAINE 4% | Guangzhou Huixue Biotechnology Co., Ltd. | 5c7245cd-80df-02de-e063-6394a90a7eaa | 2026-09-27 | Warnings | 98PI200987 |
| Lidocaine Numbing Cream | LIDOCAINE | Yyba Corp | fe986c22-a30c-4d60-90d0-5d41e0b91958 | 2026-09-25 | Warnings | 98PI200987 |
| Plantar Patch | LIDOCAINE | Active Intelligence, LLC | 5c530b12-5507-adfd-e063-6394a90afb0f | 2026-09-25 | Warnings | 98PI200987 |
| Lidocaine and prilocaine | LIDOCAINE AND PRILOCAINE | A-S Medication Solutions | f3da2c54-74bb-4186-8cc2-f80e944e12a9 | 2026-09-25 | Warnings, Adverse reactions | 98PI200987 |
| Lidocaine | LIDOCAINE | Par Health USA, LLC | 2ce8a4fe-8aa6-4dc5-ad0f-3984ae68c4bc | 2026-09-25 | Warnings, Adverse reactions | 98PI200987 |
| AIPATCH NUMBING PAIN RELIEF | LIDOCAINE | Active Intelligence, LLC | 56f27540-9b2a-4266-9e15-a5b2d738c7a1 | 2026-09-24 | Warnings | 98PI200987 |
| CVS Cold and Hot Pain Relief | LIDOCAINE, MENTHOL | CVS Pharmacy | 4a93970c-4ecd-19d5-e063-6394a90ae71c | 2026-09-24 | Warnings | 98PI200987 |
| Exchange Select ClearLax | POLYETHYLENE GLYCOL 3350 | Army & Air Force Exchange Service | 6aca8ba5-b5ec-4766-ad65-2a80b06f2fdf | 2026-09-24 | Warnings | G2M7P15E5P |
| LIDOCAINE | LIDOCAINE | Preferred Pharmaceuticals Inc. | b693e31d-8b37-4eaa-86c6-09b11ef4d1f4 | 2026-09-24 | Warnings, Adverse reactions | 1543069 98PI200987 |
| Polyethylene Glycol 3350 | POLYETHYLENE GLYCOL 3350 | Padagis Israel Pharmaceuticals Ltd | e138b8c8-48de-48cd-8baa-2cc148cef62c | 2026-09-24 | Warnings | G2M7P15E5P |
| Polyethylene glycol 3350 | POLYETHYLENE GLYCOL 3350 | Cardinal Health 107, LLC | e26457c4-03e8-430e-bfad-38ae105dbf6f | 2026-09-24 | Warnings | G2M7P15E5P |
| care one clearlax | POLYETHYLENE GLYCOL 3350 | American Sales Company | c548c557-a88f-4fcc-a297-fc4219169299 | 2026-09-24 | Warnings | G2M7P15E5P |
| Lidocaine | BURN RELIEF | Topco Associates LLC | 5faa1d39-12ce-4a65-8e53-0c040e914540 | 2026-09-23 | Warnings | 98PI200987 |
| Qvotic | LIDOCAINE PAIN RELIEF PATCH | Shenzhen Hengdasheng Technology Co., Ltd | 5c0e2414-6a76-4ae2-e063-6294a90a2a10 | 2026-09-22 | Warnings | 98PI200987 |
| leader clearlax | POLYETHYLENE GLYCOL 3350 | Cardinal Health 110, LLC. dba Leader | 812c59b0-e7ce-4c7a-91ed-e74b7b1b84be | 2026-09-22 | Warnings | G2M7P15E5P |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.